Skip to main content
Log in

Evaluation of Tp-e interval and Tp-e/QTc ratio in patients with inflammatory bowel disease

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Background

Inflammatory bowel disease (IBD), a multisystemic inflammatory disorder, has been associated with increased risk of cardiovascular problems, including complications such as conduction defects and arrhythmias. Therefore, the early assessment of the risk factors predisposing to ventricular arrhythmias is crucial, since it can improve clinical outcomes. The objective of the present study is to evaluate ventricular repolarization by using Tp‑e interval and Tp-e/QTc ratio as candidate markers of ventricular arrhythmias in patients with IBD.

Methods

The presented study was designed as a single-center prospective cohort study. The study population consisted of 175 patients with IBD and 175 healthy volunteers. The Tp‑e interval, corrected QT (QTc), and Tp-e/QTc ratio were measured from the 12-lead electrocardiogram. These parameters were compared between groups.

Results

The groups were similar in terms of electrocardiographic findings such as heart rate, QRS interval, and QTc interval. However, Tp‑e interval (87.0 ms, interquartile range, IQR 81.0–105.0 ms vs. 84.0 ms, IQR 74.0–92.0 ms; p < 0.001) and Tp-e/QTc ratio (0.21 ± 0.04 vs. 0.19 ± 0.05; p < 0.001) were significantly increased in IBD patient group compared to control group. Notably, a positive correlation was demonstrated between Tp‑e interval, Tp-e/QTc ratio and disease duration (Spearman’s Rho = 0.36, p < 0.001 for Tp‑e; Spearman’s Rho = 0.28, p < 0.001 for Tp-e/QTc).

Conclusion

This study demonstrated that IBD patients are at increased risk of disrupted ventricular repolarization (increased Tpe, Tpe/QTc ratio). In addition, a positive correlation was demonstrated between Tp‑e interval, Tp-e/QTc ratio, and disease duration. Therefore, IBD patients, especially those with long-standing diseases, should be more closely screened for ventricular arrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.

    Article  CAS  Google Scholar 

  2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–34.

    Article  CAS  Google Scholar 

  3. Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1982–92.

    Article  Google Scholar 

  4. Bunu DM, Timofte CE, Ciocoiu M, et al. Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies. Gastroenterol Res Pract. 2019;2019:3012509.

    Article  Google Scholar 

  5. Lewek J, Kaczmarek K, Cygankiewicz I, et al. Inflammation and arrhythmias: potential mechanisms and clinical implications. Expert Rev Cardiovasc Ther. 2014;12:1077–85.

    Article  CAS  Google Scholar 

  6. Castro-Torres Y, Carmona-Puerta R, Katholi RE. Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases. 2015;3:705–20.

    Article  Google Scholar 

  7. Acar G, Yorgun H, Inci MF, et al. Evaluation of Tp‑e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol. 2014;24:327–30.

    Article  Google Scholar 

  8. Acar GR, Akkoyun M, Nacar AB, et al. Evaluation of Tp‑e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars. 2014;42:29–34.

    Article  Google Scholar 

  9. Hidayet Ş, Demir V, Turan Y, et al. Evaluation of Tp‑e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with Behçet’s disease. Anatol J Cardiol. 2019;22:85–90.

    Google Scholar 

  10. Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585–95.

    Article  CAS  Google Scholar 

  11. Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227–36.

    Article  Google Scholar 

  12. Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239–54.

    Article  Google Scholar 

  13. Patel RS, Rohit Reddy S, Llukmani A, et al. Cardiovascular manifestations in inflammatory bowel disease: a systematic review of the pathogenesis and management of pericarditis. Cureus. 2021;13:e14010.

    Google Scholar 

  14. Greuter T, Rieder F, Kucharzik T, et al. Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021;70:796–802.

    Article  CAS  Google Scholar 

  15. Nevulis MG, Baker C, Lebovics E, et al. Overview of link between inflammatory bowel disease and cardiovascular disease. Cardiol Rev. 2018;26:287–93.

    Article  Google Scholar 

  16. Singh S, Singh H, Loftus EV, et al. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:382–93.

    Article  Google Scholar 

  17. Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10:429–36.

    Article  Google Scholar 

  18. Mitchell NE, Harrison N, Junga Z, et al. Heart under attack: cardiac manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2322–6.

    Article  Google Scholar 

  19. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2016;29:277–314.

    Article  Google Scholar 

  20. Rungoe C, Nyboe Andersen N, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med. 2015;25:699–704.

    Article  Google Scholar 

  21. Zanoli L, Rastelli S, Granata A, et al. Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis. J Hypertens. 2016;34:822–9.

    Article  CAS  Google Scholar 

  22. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329–42.

    Article  CAS  Google Scholar 

  23. Tan VP, Chung A, Yan BP, Gibson PR. Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol. 2013;28:1095–113.

    Article  Google Scholar 

  24. Engel T, Ben-Horin S, Beer-Gabel M. Autonomic dysfunction correlates with clinical and inflammatory activity in patients with Crohn’s disease. Inflamm Bowel Dis. 2015;21:2320–6.

    Google Scholar 

  25. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2017;2018(72):e91–e220.

    Google Scholar 

  26. Arteyeva NV. Dispersion of ventricular repolarization: Temporal and spatial. World J Cardiol. 2020;12:437–49.

    Article  Google Scholar 

  27. Erikssen G, Liestøl K, Gullestad L, et al. The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol. 2012;17:85–94.

    Article  Google Scholar 

  28. Gupta P, Patel C, Patel H, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41:567–74.

    Article  Google Scholar 

  29. Zhao X, Xie Z, Chu Y, et al. Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol. 2012;35:559–64.

    Article  Google Scholar 

  30. Candemir M, Candemir B, Ertürk A. Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring. Clin Rheumatol. 2020;39:2631–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to İbrahim Ethem Güven MD.

Ethics declarations

Conflict of interest

İ. E. Güven, M. Candemir, B. Başpınar, R. E. Cankurtaran, and E. Kayaçetin declare that they have no conflict of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Güven, İ.E., Candemir, M., Başpınar, B. et al. Evaluation of Tp-e interval and Tp-e/QTc ratio in patients with inflammatory bowel disease. Wien Klin Wochenschr 135, 14–21 (2023). https://doi.org/10.1007/s00508-022-02100-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-022-02100-4

Keywords

Navigation